1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. More Details
Imperfect balance sheet and overvalued.
Share Price & News
How has 1933 Industries's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TGIF is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: TGIF's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
7 Day Return
1 Year Return
Return vs Industry: TGIF underperformed the Canadian Pharmaceuticals industry which returned 47.2% over the past year.
Return vs Market: TGIF underperformed the Canadian Market which returned 1.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is 1933 Industries's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 months ago | Simply Wall StOne Analyst Just Downgraded Their 1933 Industries Inc. (CSE:TGIF) Forecasts
7 months ago | Simply Wall StIntroducing 1933 Industries (CSE:TGIF), The Stock That Tanked 75%
11 months ago | Simply Wall StHave Insiders Been Buying 1933 Industries Inc. (CSE:TGIF) Shares?
Is 1933 Industries undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate TGIF's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate TGIF's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: TGIF is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.
PE vs Market: TGIF is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate TGIF's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: TGIF is good value based on its PB Ratio (1.6x) compared to the CA Pharmaceuticals industry average (2.7x).
How is 1933 Industries forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as 1933 Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of TGIF’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- 1933 Industries competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has 1933 Industries performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TGIF is currently unprofitable.
Growing Profit Margin: TGIF is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TGIF is unprofitable, and losses have increased over the past 5 years at a rate of 51.3% per year.
Accelerating Growth: Unable to compare TGIF's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TGIF is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-61.1%).
Return on Equity
High ROE: TGIF has a negative Return on Equity (-101.6%), as it is currently unprofitable.
How is 1933 Industries's financial position?
Financial Position Analysis
Short Term Liabilities: TGIF's short term assets (CA$7.2M) do not cover its short term liabilities (CA$12.2M).
Long Term Liabilities: TGIF's short term assets (CA$7.2M) do not cover its long term liabilities (CA$14.5M).
Debt to Equity History and Analysis
Debt Level: TGIF's debt to equity ratio (53.7%) is considered high.
Reducing Debt: Insufficient data to determine if TGIF's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TGIF has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: TGIF is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.
What is 1933 Industries's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TGIF's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TGIF's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TGIF's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TGIF's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TGIF's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Paul Rosen (56 yo)
Mr. Paul Rosen, LLB serves as a Director of Delic Holdings Inc. Mr. Rosen serves as Non-Executive Chairman at Stemcell United Limited since November 2020. Mr. Rosen serves as a Member of Advisory Board at ...
|Executive VP & General Counsel||3yrs||CA$219.77k||0.62% |
|CEO & Director||0.58yr||no data||3.46% |
|President||0.58yr||no data||0.29% |
|Chief Financial Officer||0.50yr||no data||no data|
|Vice President of Investor Relations||2yrs||no data||0.012% |
|Company Secretary||2.58yrs||no data||no data|
Experienced Management: TGIF's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
|CEO & Director||0.58yr||no data||3.46% |
|Independent Director||5.17yrs||no data||2.08% |
|Independent Director||4.75yrs||CA$15.00k||0.39% |
|Independent Director||1yr||no data||no data|
|Member of Advisory Board||3.42yrs||no data||no data|
|Member of Advisory Board||3.5yrs||no data||no data|
|Independent Non-Executive Chairman||1yr||no data||0.044% |
|Independent Director||1yr||no data||no data|
Experienced Board: TGIF's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.2%.
1933 Industries Inc.'s company bio, employee growth, exchange listings and data sources
- Name: 1933 Industries Inc.
- Ticker: TGIF
- Exchange: CNSX
- Founded: 2008
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$33.686m
- Shares outstanding: 354.59m
- Website: https://www.1933Industries.com
Number of Employees
- 1933 Industries Inc.
- 1055 West Hastings Street
- Suite 300
- British Columbia
- V6E 2E9
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|TGIF.F||OTCPK (Pink Sheets LLC)||Yes||New Common Shares||US||USD||Dec 2015|
|1QF||DB (Deutsche Boerse AG)||Yes||New Common Shares||DE||EUR||Dec 2015|
|TGIF||CNSX (Canadian National Stock Exchange)||Yes||New Common Shares||CA||CAD||Dec 2015|
1933 Industries Inc., a cannabis company, engages in the cultivation and production of medical marijuana in the United States and Canada. It operates in AMA and Infused MFG segments. The company operates i...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/16 23:57|
|End of Day Share Price||2021/01/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.